Literature DB >> 1921145

Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes.

R D Harris1, M W Steffes, R W Bilous, D E Sutherland, S M Mauer.   

Abstract

We studied the lesions of global glomerular sclerosis and arteriolar hyalinosis in 43 (29 females) insulin-dependent diabetes mellitus (IDDM) patients whose creatinine clearance (CCr) was greater than or equal to 45 ml/min/1.73 m2 and whose renal biopsies had at least 20 glomeruli available for study. These patients, ages 17 to 55 years, had IDDM for 7 to 32 (20 +/- 6, means +/- SD) years. CCr ranged from 47 to 139 (91 +/- 25) ml/min/1.73 m2 and urinary albumin excretion (UAE) from 5 to 3386 (median = 127) mg/24 hrs. Eighteen patients were hypertensive. Thus, these patients represented a broad clinical range from normal renal function through overt diabetic nephropathy. The percent of glomeruli which were globally sclerosed was strongly correlated with CCr (r = -0.64, P less than 0.0001) and log UAE (r = +0.67, P less than 0.001). Hypertension was more common in patients with more than 10% sclerosed glomeruli (chi square = 9.5, P less than 0.002). Percent sclerosed glomeruli was highly significantly correlated with the index of severity of the arteriolar hyalinosis lesion (r = +0.66, P less than 0.0001) and mesangial volume fraction (r = +0.61, P less than 0.0001). We hypothesize that arteriolar hyalinosis could contribute to global glomerular sclerosis through severe compromise of glomerular blood flow. Alternately, global glomerular sclerosis may result from marked mesangial expansion and capillary occlusion. However, in this broad range of patients it appeared that global glomerular sclerosis and mesangial expansion were not infrequently independent diabetic renal lesions which could contribute separately to the ultimate development of overt diabetic nephropathy.

Entities:  

Mesh:

Year:  1991        PMID: 1921145     DOI: 10.1038/ki.1991.187

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.

Authors:  Ming Lu; Jianzhong Zhang; Ming Li; Xiaoxu Ge; Xu Dai; Jiao Zhao; Mingzhou Fu; Tao Wang; Xiyao Fang; Can Li; Rong Zhang; Weijing Zhao; Taishan Zheng; Feng Wang; Ming Yu; Tao Lei; Niansong Wang; Yuqian Bao; Limei Liu; Yanjun Liu; Weiping Jia
Journal:  Mol Cell Biochem       Date:  2016-09-16       Impact factor: 3.396

Review 2.  Update on glycemic control for the treatment of diabetic kidney disease.

Authors:  Girish N Nadkarni; Rabi Yacoub; Steven G Coca
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 3.  Glomerular structural-functional relationship models of diabetic nephropathy are robust in type 1 diabetic patients.

Authors:  Michael Mauer; Maria Luiza Caramori; Paola Fioretto; Behzad Najafian
Journal:  Nephrol Dial Transplant       Date:  2014-09-01       Impact factor: 5.992

4.  Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients.

Authors:  Paola Fioretto; Behzad Najafian; David E R Sutherland; Michael Mauer
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

5.  In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone.

Authors:  Jørn P Lindahl; Finn P Reinholt; Ivar A Eide; Anders Hartmann; Karsten Midtvedt; Hallvard Holdaas; Linda T Dorg; Trine M Reine; Svein O Kolset; Rune Horneland; Ole Øyen; Knut Brabrand; Trond Jenssen
Journal:  Diabetologia       Date:  2014-08-22       Impact factor: 10.122

Review 6.  Morphologic features of declining renal function in type 1 diabetes.

Authors:  Behzad Najafian; Michael Mauer
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 7.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 8.  Temporal profile of diabetic nephropathy pathologic changes.

Authors:  Cecilia Ponchiardi; Michael Mauer; Behzad Najafian
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

9.  Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.

Authors:  J T Tamsma; J van den Born; J A Bruijn; K J Assmann; J J Weening; J H Berden; J Wieslander; E Schrama; J Hermans; J H Veerkamp
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

10.  Renal lesions predict progression of diabetic nephropathy in type 1 diabetes.

Authors:  M Luiza Caramori; Alicia Parks; Michael Mauer
Journal:  J Am Soc Nephrol       Date:  2013-05-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.